chr14-24233522-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001002002.3(GMPR2):c.131C>T(p.Thr44Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000239 in 1,613,974 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001002002.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GMPR2 | NM_001002002.3 | c.131C>T | p.Thr44Ile | missense_variant | 3/10 | ENST00000399440.7 | NP_001002002.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GMPR2 | ENST00000399440.7 | c.131C>T | p.Thr44Ile | missense_variant | 3/10 | 1 | NM_001002002.3 | ENSP00000382369 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000337 AC: 84AN: 249506Hom.: 0 AF XY: 0.000295 AC XY: 40AN XY: 135370
GnomAD4 exome AF: 0.000241 AC: 352AN: 1461642Hom.: 1 Cov.: 31 AF XY: 0.000249 AC XY: 181AN XY: 727152
GnomAD4 genome AF: 0.000223 AC: 34AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 21, 2021 | The c.185C>T (p.T62I) alteration is located in exon 2 (coding exon 2) of the GMPR2 gene. This alteration results from a C to T substitution at nucleotide position 185, causing the threonine (T) at amino acid position 62 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at